VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ)
$521.03 3.54 (0.6841%)
Analysed VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) News Sources
Gilead Sciences (GILD) vs. AMGN and VRTX: Can Oncology Growth and HIV Strength Drive a New Growth Era Beyond Acquisitions?
22-10-2026
yahoo.com
Vertex Pharmaceuticals’ New Drugs Are Gaining Ground. Is That Enough for Investors?
21-10-2026
yahoo.com
Vertex Stock Looks Expensive. Does It Get Cheaper Ahead?
23-10-2026
trefis.com
Vertex Highlights Kidney Pipeline as Povetacicept Cuts Proteinuria 52% in Phase III
24-10-2026
marketbeat.com
Vertex Pharmaceuticals Gets 96% of Product Sales From Treatments for 1 Disease. Here's Why That's About to Change.
24-10-2026
fool.com
Vertex Pharmaceuticals (VRTX) Posts Positive Phase 3 Results For Povetacicept
25-10-2026
yahoo.com
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
26-10-2026
yahoo.com
The $500 Million Non-CF Factor Vertex Investors Can’t Ignore on Nov. 2
26-10-2026
247wallst.com
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
27-10-2026
yahoo.com
Amgen vs. Vertex Pharmaceuticals: Massive Pharmaceutical Scale vs. Steady Drug Revenue
27-10-2026
fool.com
What is the current price of VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ)?
The current price of VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) is $521.03.
VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) since the previous trading day is $3.54.
VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) since the previous trading day is 0.6841%.
What is the most recent average sentiment score for VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ)?
The most recent average sentiment score for VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ)?
The most recent sentiment for VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ) is .
SEC-8K** Filing Available For VERTEX PHARMACEUTICALS INC (VRTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.